APLT Stock Summary and Trading Ideas (Applied Therapeutics | NASDAQ:APLT)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics trades on the NASDAQ stock market under the symbol APLT.

As of April 18, 2024, APLT stock price declined to $4.74 with 691,887 million shares trading.

APLT has a beta of -0.98, meaning it tends to be less sensitive to market movements. APLT has a correlation of 0.01 to the broad based SPY ETF.

APLT has a market cap of $501.90 million. This is considered a Small Cap stock.

In the last 3 years, APLT stock traded as high as $25.59 and as low as $.50.

The top ETF exchange traded funds that APLT belongs to (by Net Assets): VTI, VXF, DWAS, IWC, AVUS.

APLT has outperformed the market in the last year with a return of +457.6%, while the SPY ETF gained +22.3%. In the last 3 month period, APLT beat the market returning +93.5%, while SPY returned +6.1%. However, in the most recent 2 weeks APLT has underperformed the stock market by returning -23.7%, while SPY returned -3.8%.

APLT support price is $4.57 and resistance is $5.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APLT stock will trade within this expected range on the day.